Real-time PCR Assay for Omicron Variant Detection

Real-time PCR kit for qualitative detection of SARS-CoV-2 (2019-nCoV) nucleic acids in respiratory specimens. Enables rapid molecular diagnosis of COVID-19 infection with high sensitivity and specificity. Suitable for clinical laboratories and diagnostic facilities requiring timely pathogen identification.

Real-time PCR assay for qualitative detection of SARS-CoV-2 nucleic acid in respiratory samples. Provides rapid identification of COVID-19 infection for clinical diagnosis.

A diagnostic kit for SARS-CoV-2 detection using real-time PCR technology. It provides comprehensive detection capability by simultaneously testing for ORF1a/b and N gene sequences with included internal controls achieving sensitivity down to 10 copies. The kit includes contamination prevention measures through dUTP and UDG enzyme incorporation. It offers convenient and rapid testing with 10 minutes of hands-on operation and completion of detection within 2.5 hours, suitable for large-scale rapid screening applications.

Molecular diagnostic assay for SARS-CoV-2 detection with high sensitivity and specificity. Delivers reliable results for COVID-19 diagnosis in clinical and point-of-care settings.

Real-time PCR kit for detection of SARS-CoV-2 virus in respiratory samples.

Molecular diagnostic kit for routine polymerase chain reaction detection of SARS-CoV-2 in clinical samples. Used in laboratory settings for confirmation of COVID-19 infection.

A nucleic acid test kit for qualitative detection of SARS-CoV-2 (2019-nCoV) in vitro specimens. This diagnostic test kit utilizes PCR technology for accurate identification of COVID-19 infection.

PCR-based nucleic acid detection kit for COVID-19 diagnosis using fluorescent probe technology. Designed for rapid and accurate identification of SARS-CoV-2 in clinical respiratory samples. Enables quantitative and qualitative analysis in laboratory and point-of-care settings.

A diagnostic test kit for nucleic acid detection of SARS-CoV-2. This molecular test enables identification of active COVID-19 infections in clinical samples.

Molecular diagnostic kits for detecting SARS-CoV-2 RNA in respiratory and other clinical samples. Enables rapid COVID-19 diagnosis for clinical and screening purposes.

RT-qPCR detection kit for SARS-CoV-2 identification in clinical samples. This CE-IVD marked assay enables rapid molecular diagnosis of COVID-19 through real-time quantitative PCR, suitable for laboratory and point-of-care testing environments. The kit provides sensitive and specific viral detection for respiratory samples.

This detection cartridge uses real-time reverse transcription PCR method for COVID-19 nucleic acid detection. COVID-19 is an acute respiratory infectious disease caused by novel coronaviruses belonging to the β genus, to which people are generally susceptible. The main source of infection is patients infected by the novel coronavirus; asymptomatic infected people can also be infectious sources. The incubation period is typically 1 to 14 days, mostly 3 to 7 days. Main manifestations include fever, fatigue, and dry cough, with nasal congestion, runny nose, sore throat, myalgia, and diarrhea occurring in some cases.